Lanthanoid endohedral metallofullerenols for MRI contrast agents.
about
Physicochemical characterization, and relaxometry studies of micro-graphite oxide, graphene nanoplatelets, and nanoribbonsNanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?Non-destructive inhibition of metallofullerenol Gd@C(82)(OH)(22) on WW domain: implication on signal transduction pathwayMolecular mechanism of pancreatic tumor metastasis inhibition by Gd@C82(OH)22 and its implication for de novo design of nanomedicineOpen-cage fullerenes: towards the construction of nanosized molecular containersMetallofullerenol Gd@C₈₂(OH)₂₂ distracts the proline-rich-motif from putative binding on the SH3 domain.Applications of functionalized fullerenes in tumor theranostics.Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis.Enhanced MRI relaxivity of aquated Gd3+ ions by carboxyphenylated water-dispersed graphene nanoribbons.Gadofullerene MRI contrast agents.Biomedical Applications of Metal-Encapsulated Fullerene Nanoparticles.Water-soluble fullerene (C60) derivatives as nonviral gene-delivery vectors.Quantitative bone matrix density measurement by water- and fat-suppressed proton projection MRI (WASPI) with polymer calibration phantoms.Facile preparation of a new gadofullerene-based magnetic resonance imaging contrast agent with high 1H relaxivity.High relaxivity trimetallic nitride (Gd3N) metallofullerene MRI contrast agents with optimized functionality.The reactivity of endohedral fullerenes. What can be learnt from computational studies?Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics.Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.Bottom-up formation of endohedral mono-metallofullerenes is directed by charge transfer.Mechanisms of Gadographene-Mediated Proton Spin Relaxation.Gd2@C79N: isolation, characterization, and monoadduct formation of a very stable heterofullerene with a magnetic spin state of S = 15/2Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats.Endohedral clusterfullerenes--playing with cluster and cage sizes.Destroying gadofullerene aggregates by salt addition in aqueous solution of Gd@C(60)(OH)(x) and Gd@C(60)[C(COOH(2))](10)Fate and toxicity of metallic and metal-containing nanoparticles for biomedical applications.Interactions between proteins and carbon-based nanoparticles: exploring the origin of nanotoxicity at the molecular level.Nanomedicine: de novo design of nanodrugs.Gadolinium-containing endohedral fullerenes: structures and function as magnetic resonance imaging (MRI) agents.Dual inhibitory pathways of metallofullerenol Gd@C₈₂(OH)₂₂ on matrix metalloproteinase-2: molecular insight into drug-like nanomedicine.Encapsulated gadolinium and dysprosium ions within ultra-short carbon nanotubes for MR microscopy at 11.75 and 21.1 T.De novo design of an endohedral heteronuclear dimetallofullerene (U-Gd)@C60 with exceptional structural and electronic properties.The key energy scales of Gd-based metallofullerene determined by resonant inelastic x-ray scattering spectroscopy.A platform for specific delivery of lanthanide-scandium mixed-metal cluster fullerenes into target cells.Conjugation of functionalized gadolinium metallofullerenes with IL-13 peptides for targeting and imaging glial tumors.A crystalline anionic complex of scandium nitride endometallofullerene: experimental observation of single-bonded (Sc3N@Ih-C80(-))2 dimers.Molecular Basis for the Recognition of Higher Fullerenes into Ureidopyrimidinone-Cyclotriveratrylene Self-Assembled Capsules.Study on the antigenicity of metallofullerenol: antibody production, characterization, and its enzyme immunoassay application.Fullerenes in Biology and Medicine.Analysis of polyvinyl alcohol microbubbles in human blood plasma using capillary electrophoresis.Ti12C68: A stable T h -symmetry hollow cage.
P2860
Q21134550-1A09D993-DF69-42E1-8759-540E0CADD4B8Q24599399-726F03E7-ABEA-4FB8-8AB5-30A491C2C120Q24601143-B4151F70-4CC4-4E45-A551-9319DA7C85A2Q24633644-538051EC-5AA5-4FFE-B53B-E87A4548993CQ28271748-BAC89786-D97E-48B3-B6B9-F42A8FEB21D2Q30009919-70AC61AD-AF0E-457B-9BEB-C10BB467A127Q30468506-820A9D24-0AC5-460F-A831-DCA2E86570ABQ30494430-265D626C-EDFF-4D59-90BB-A5C655BA2ADAQ30750984-8C78CB6A-97B6-4A3C-9582-15747E0CB312Q31150936-AD5E94DA-A56F-441E-9C02-66C360DCF4AAQ31151525-888CF5DD-1D93-48C5-8238-EDA9BE6BD3DDQ31156684-2B303B68-F48B-4B30-88C6-4D69C19B3966Q33386355-E70063A2-71C8-4330-A6FD-9E53DC77C21AQ33445981-D9293015-AD8B-4CD4-A8A2-A8CFF7535F8AQ33539375-1EB868A1-219F-4F54-93C5-1F1629A3BC3DQ33756358-CDC869C4-25EB-45AF-BE05-97489288D0E3Q33759720-3096A173-4CAB-4D36-B4FE-FD92931615CDQ33847006-43AEEFFD-2EE3-4EF0-B8AC-27AAA42506B0Q34454752-E498ACC1-0E8E-4F95-9862-D082CDF7881CQ35057923-E9791A37-EA91-45E0-B154-CCFA5B6D02C1Q35093105-301E2526-8840-4424-A915-CC10AD5DF3E7Q36125194-83F7E530-6E3B-40C4-8828-314045D13CB7Q36870948-45656322-4318-4354-857D-363EE00E006EQ37003300-48435193-4539-4A2B-8AB3-4BE852134B35Q37935681-AA1253DB-BD1C-477E-8FAF-D2DDF692F751Q38049565-2CD599E9-2C11-43DD-B5A7-650D015326B4Q38168683-1DFD0A41-EDC9-4543-B092-ADBDDF3ACAFAQ38187571-078FD803-0643-4D2A-90D1-5A1D2F496436Q38938415-66D71A43-27C6-4849-9AA3-4AFE157AA7FEQ39029771-C33D3EF3-C8D9-4C0D-87FA-7E17C42025B1Q39136715-95C7CBBE-235E-428C-8239-D4C11BEE8B6AQ41420084-5EE3C7F9-E2BE-42DA-ADE6-14CB19B64E68Q41951086-627C9387-8B2E-440C-94F7-F659D65A21B5Q43435447-00BADC9D-032A-4A1D-9667-0DC49E9524ADQ47136459-89E4A8B9-C816-4580-BA07-8CBA3DD50400Q48163793-DC35EDA8-3E8E-4C23-AC9E-AF29366A84FFQ49908646-FF557EA5-DFBB-411E-A223-05EAFF9814D2Q49960476-FB7D7EE8-673B-4A0F-9EDB-1FFA3A8770D4Q51495278-89145935-CD42-47A3-BA0B-8010C3C547EEQ55318208-A02AE545-B425-489C-A9F6-F1C80DBC32C6
P2860
Lanthanoid endohedral metallofullerenols for MRI contrast agents.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Lanthanoid endohedral metallofullerenols for MRI contrast agents.
@ast
Lanthanoid endohedral metallofullerenols for MRI contrast agents.
@en
type
label
Lanthanoid endohedral metallofullerenols for MRI contrast agents.
@ast
Lanthanoid endohedral metallofullerenols for MRI contrast agents.
@en
prefLabel
Lanthanoid endohedral metallofullerenols for MRI contrast agents.
@ast
Lanthanoid endohedral metallofullerenols for MRI contrast agents.
@en
P2093
P356
P1476
Lanthanoid endohedral metallofullerenols for MRI contrast agents.
@en
P2093
Atsushi Taninaka
Haruhito Kato
Hisanori Shinohara
Masafumi Okumura
Takashi Yokawa
Yoko Kanazawa
P304
P356
10.1021/JA027555+
P407
P577
2003-04-01T00:00:00Z